Iwamoto I, Ueki I, Nadel J A
Department of Medicine, University of California, San Francisco 94143-0130.
Neuropeptides. 1988 May-Jun;11(4):185-93. doi: 10.1016/0143-4179(88)90074-1.
To determine whether neutral endopeptidase regulates the binding of substance P to the receptors, and if so, what the mechanism is, we determined the effect of neutral endopeptidase inhibitors, thiorphan and phosphoramidon, on specific binding of 3H-substance P to homogenates of rat ileum. Specific binding was of high affinity and was saturable (dissociation constant, KD = 2.4 +/- 0.17 nM and number of maximal binding sites, Bmax = 101.1 +/- 5.5 fmol/mg protein), and the receptor subtype was substance P-P type. Neutral endopeptidase inhibitors increased the specific binding to up to 160% of control (P less than 0.005). Neutral endopeptidase inhibitors prevented the degradation of 3H-substance P during the binding assay and increased the amount of 3H-substance P remaining in the assay system to up to 4.5-fold of control (P less than 0.005), but did not significantly change the KD or Bmax values of specific binding. Protease inhibitors of kininase II, serine proteinases, or thiol proteinases did not significantly change either specific binding or the amount of 3H-substance P remaining in the assay system. We conclude that neutral endopeptidase regulates the binding of substance P to the receptors and that it does so by decreasing the amount of substance P available to the receptors, without significantly changing the affinity or the number of receptors.
为了确定中性内肽酶是否调节P物质与受体的结合,若如此,其机制是什么,我们测定了中性内肽酶抑制剂噻吗洛尔和磷酰胺素对3H-P物质与大鼠回肠匀浆特异性结合的影响。特异性结合具有高亲和力且可饱和(解离常数KD = 2.4±0.17 nM,最大结合位点数Bmax = 101.1±5.5 fmol/mg蛋白质),受体亚型为P物质-P型。中性内肽酶抑制剂使特异性结合增加至对照的160%(P<0.005)。中性内肽酶抑制剂在结合测定过程中阻止了3H-P物质的降解,并使测定系统中剩余的3H-P物质的量增加至对照的4.5倍(P<0.005),但未显著改变特异性结合的KD或Bmax值。激肽酶II、丝氨酸蛋白酶或巯基蛋白酶的蛋白酶抑制剂均未显著改变特异性结合或测定系统中剩余的3H-P物质的量。我们得出结论,中性内肽酶调节P物质与受体的结合,其方式是减少可与受体结合的P物质的量,而不显著改变受体的亲和力或数量。